Nothing specific on today's action but they did say that they are still talking to Rio Grande regarding a partial ownership deal. The last statement I saw sounded like the deal was dead so the fact that they continue to negotiate is interesting.
Uplisting is still a priority.
The animal myocardial infarction pre-clinical study is on track for early April completion. Human trials will then start assuming positive results.